The additional share issuance capacity of resolution 3 of 10% is only available for a company which is not in the ASX 300 und/ or below a market cap of 300 mil.
I agree, this capacity is kept in case, but will need shareholder approval on the 23rd, allowing company to be able to offer potential partners a large stake in the company.
This could well be a condition for a partner to proceed, so it seems unlikely that our broker lets market grow past 300 mil prior to the 23rd.
Meanwhile , sentiment currently swings to positive and price developments after the AGM could be swift, particularly if management provides additional sweeteners at the meeting,
all IMO
- Forums
- ASX - By Stock
- PYC
- Ann: Successful Toxicology Studies Pave Way for Human Trials
PYC
pyc therapeutics limited
Add to My Watchlist
4.23%
!
$1.25

Ann: Successful Toxicology Studies Pave Way for Human Trials, page-20
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.25 |
Change
-0.055(4.23%) |
Mkt cap ! $726.1M |
Open | High | Low | Value | Volume |
$1.26 | $1.26 | $1.24 | $173.1K | 139.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 33352 | $1.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.30 | 7691 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 33352 | 1.240 |
2 | 1833 | 1.200 |
1 | 10000 | 1.190 |
3 | 10888 | 1.180 |
1 | 1702 | 1.175 |
Price($) | Vol. | No. |
---|---|---|
1.300 | 7691 | 1 |
1.310 | 7427 | 1 |
1.320 | 10000 | 1 |
1.335 | 475 | 1 |
1.340 | 9300 | 1 |
Last trade - 16.10pm 07/08/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |